Skip to main content
. Author manuscript; available in PMC: 2022 Sep 5.
Published in final edited form as: Int J Pharm. 2021 Jul 10;606:120877. doi: 10.1016/j.ijpharm.2021.120877

Table 7.

Data for accelerated stability studies

Time intervals Conditions Viscosity (cps) Drug content (%) % drug release at the end of 48h

Initial 5±3°C 6809 ± 8.50 99.56 ± 2.91 84.67 ± 5.67
25°C ± 2°C/60% RH ± 5% RH 6978 ±12.64 98.93 ± 2.06 85.23 ± 4.82
2 months 5±3°C 6782 ± 10.22 98.85 ± 3.05 82.98 ± 6.75
25°C ± 2°C/60% RH ± 5% RH 6964 ± 17.03 93.21 ± 5.87 86.01 ± 4.52
4 months 5±3°C 6868 ± 8.63 96.32 ± 3.81 83.44 ± 6.31
25°C ± 2°C/60% RH ± 5% RH 6772 ± 18.06 91.80 ± 6.64 85.61 ± 5.23